The first study of its kind designed to test the effects of a diet on the decline of cognitive abilities among a large group of individuals 65 to 84 years who currently do not have cognitive impairment has begun.
In response to a growing body of evidence of the existence of “covert” brain injury to patients undergoing transcatheter aortic valve implantation (TAVI) and other cardiac procedures, The Neurologic Academic Research Consortium (NeuroARC) has announced the simultaneous publication of a consensus paper offering a new classification of neurologic outcomes and testing to better ensure the safety of cardiac procedures. The paper is available online, and will be published in the Journal of American College of Cardiology and a future issue of the European Heart Journal.
In 2016, Penumbra announced the launch of the ACE68 reperfusion catheter, part of the Penumbra System at the Society of NeuroInterventional Surgery 13th Annual Meeting (SNIS; 25–28 July, Boston, USA).
A new study has found stent-assisted endovascular techniques with Acclino stents (Acandis) are a feasible treatment for complex intracranial aneurysms. Reporting in the Journal of Neurointerventional Surgery (JNIS), the authors report that even in challenging complex bifurcation aneurysms they achieved good treatment results using the kissing-Y stenting technique.
The first patient has been enrolled in the ENRICH (Early minimally-invasive removal of ICH) randomised clinical trial (RCT). This trial is designed to determine the procedural safety, as well as the economic and functional benefit, of early surgical removal of intracerebral haemorrhage using the BrainPath Approach compared to the medical management standard of care. The BrainPath Approach uses a combination of technologies, including the FDA-cleared NICO BrainPath (NICO Corporation) for non-disruptive access and NICO Myriad to achieve the goal of maximum clot evacuation.
A study published in the Journal of Anatomy has made a breakthrough in the examination of blood vessels in the brain, giving scientists a clearer understanding of how dementia, brain cancer and stroke can affect veins and capillaries in this organ.
BrainScope has announced the market release of its flagship Ahead 300 product, and will initiate a limited launch to a select group of thought leaders through its Centers of Excellence programme later in the first quarter. These institutions will represent a cross-section of market segments including Urgent Care Clinics, Concussion Clinics, Emergency Medicine Departments, and University and Professional Sports.
A new study has shown that older people who followed a “Mediterranean diet” retain more brain volume over a three-year period than those who have not followed the diet as closely. The research was published online in Neurology. Contrary to earlier studies, researchers also found no relation between the proportion of fish and meat consumed by participants, and changes in the brain.
Amnis Therapeutics has received approval to perform a first-in-human clinical trial with its neuro thrombectomy device, the Golden Retriever. The approval was received from the Karolinska Institute (Stockholm, Sweden).
According to a report of a single centre’s experience using the Medina embolisation device (Medtronic) for the treatment of unruptured aneurysms, the device “represents a major step forward” in the treatment of intracranial aneurysms.
UCLA researchers have shown that the brain can be repaired—and brain function can be recovered—after a stroke in animals. The discovery could have important implications for treating a mind-robbing condition known as a white matter stroke, a major cause of dementia.
Codman Neuro has announced the acquisition of Pulsar Vascular Inc, a privately-held company with breakthrough platform technology for the neurovascular treatment of complex aneurysms. DePuy Synthes Products Inc, an affiliate of Codman Neuro, is the acquiring entity.
Comparing the outcomes on computed tomography (CT) perfusion of patients with large baseline ischaemic cores undergoing endovascular therapy with the outcomes of matched controls who had medical care alone, Leticia C Rebello and colleagues from the Grady Memorial Hospital, Emory University School of Medicine, Atlanta, USA, found that, in properly selected patients, endovascular therapy appears to benefit patients with large core and large mismatch profiles.
Investigators using the p64 Flow Modulation Device (Phenox) for the treatment of unruptured intracranial aneurysms at six centres have revealed that mid- and long-term follow-up show that endovascular treatment with the p64 Flow Modulation Device is a safe treatment for unruptured cerebral aneurysms, resulting in a high rate of occlusion.
The US Food and Drug Administration (FDA) has cleared an expanded indication for the Solitaire stent retriever device (Medtronic). The FDA now allows the marketing of the Solitaire device as an initial therapy for acute ischaemic strokes for patients with a persistent, proximal anterior circulation, large vessel occlusion, and smaller core infarcts to reduce paralysis, speech difficulties and other stroke-related disabilities. The device should be used after patients have received intravenous tissue plasminogen activator (IV t-PA) and within six hours of symptom onset.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos